Understanding how pancreatic cancer resists neoantigen vaccines
Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
This study is looking into why some people with pancreatic cancer don't respond to special vaccines that help the immune system fight cancer, and it's for patients who are interested in how these vaccines might work better for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10916347 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind why some pancreatic cancer patients do not respond to neoantigen vaccines, which are designed to stimulate the immune system against cancer cells. The team has developed advanced software tools to predict neoantigens and is conducting clinical trials to test the effectiveness of these vaccines in patients. By analyzing immune responses in patients treated with these vaccines, the researchers aim to enhance the design of future therapies. The study focuses on optimizing vaccine formulations to improve immune responses in patients with pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) who are undergoing neoadjuvant chemotherapy.
Not a fit: Patients with advanced pancreatic cancer who are not eligible for neoadjuvant therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer vaccines that improve treatment outcomes for pancreatic cancer patients.
How similar studies have performed: Previous research has shown promising results with neoantigen vaccines in other cancer types, indicating potential for success in this area as well.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Hawkins, William G — Washington University
- Study coordinator: Hawkins, William G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.